Aflac Incorporated (NYSE: AFL) announced today that it will release fourth quarter 2025 financial results after the market closes on Wednesday, February 4, 2026. At that time, earnings materials, including the quarterly earnings release and financial supplement, will be available, along with a financial update video from Senior Executive Vice President and Chief Financial Officer […]

AAR CORP. (NYSE: AIR), a leading provider of aviation services to commercial and government operators, MROs, and OEMs, announced today Trax and Aerostrat were recently selected by Thai Airways to drive the airline's digital MRO transformation. https://mma.prnewswire.com/media/2305023/AAR_Logo.jpg Trax's eMRO enterprise resource planning system, suite of eMobility apps, and cloud hosting solution will support the modernization

Brixmor Property Group Inc. (NYSE: BRX) (“Brixmor” or the “Company”) announced today investment activity for the three and twelve months ended December 31, 2025. This activity reflectsBrixmor's disciplined strategy of clustering its portfolio in attractive markets where the Company can leverage its platform to deliver long-term value and earnings growth, while harvesting assets where value

The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Klarna Group plc (NYSE: KLAR) securities pursuant and/or traceable to Klarna's offering documents issued in connection with Klarna's September 10, 2025 initial public offering (“IPO”), have until February 20, 2026 to seek appointment as lead plaintiff of the Klarna

Viking Therapeutics, Inc. (“Viking”) (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, todayannounced that its chief executive officer, Brian Lian, Ph.D., will deliver a corporate presentation at the 44th Annual J.P. Morgan Healthcare Conference. The conference will take place January 12-15, 2026, in San Francisco,

Neurocrine Biosciences, Inc. (Nasdaq: NBIX) will present at the 44th Annual J.P. Morgan Healthcare Conference at 9:45 a.m. Pacific Time on Monday, January 12, 2026, in San Francisco. Kyle Gano, Chief Executive Officer, will present at the conference. https://mma.prnewswire.com/media/678850/Neurocrine_Biosciences_Logo.jpg The live presentation will be webcast and can be accessed on Neurocrine Biosciences' website under Investors

Following the recent military operation in Venezuela and the resulting airspace shutdown, tens of thousands of travelers are facing unexpected flight cancellations, delays, and missed connections. InsureMyTrip reports close to 1,000 of its customers may be directly impacted, with travelers currently unable to fly in or out of affected areas. As airlines adjust schedules and

Every worker deserves an equal opportunity and a safe work environment. Yet many workers-especially women, Indigenous peoples, persons with disabilities and members of visible minorities-continue to face barriers to equity and experience harassment and violence at work. Today, the Government of Canadalaunched calls for proposals to supportinnovative projects that will help create safer, more inclusive,

The Association for Diagnostics & Laboratory Medicine (ADLM) has released updated expert guidance on urine drug testing for patients in the emergency department (ED). As drug misuse and testing methods continue to evolve, this guidance will help laboratory medicine professionals and clinicians to collaborate on selecting the most appropriate tests for drug detection, which in

SouthState Bank Corporation (NYSE: SSB) (“SouthState” or the “Company”) announced today that it will release fourth quarter 2025 earnings results on Thursday, January 22, 2026, after the market closes. Upon release, investors may access a copy ofSouthState's earnings results at the Company's website at www.SouthStateBank.com under Investor Relations, News, News & Market Data section. SouthState